Weed (BUDZ) Shares Outstanding (Weighted Average) (2010 - 2026)
Weed (BUDZ) recorded quarterly Shares Outstanding (Weighted Average) of $148.3 million in Q1 2026, up 0.6% quarter-over-quarter from $147.4 million in Q4 2025, and up 9.11% on a YoY basis from $135.9 million in Q1 2025.
Weed (BUDZ) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Weed's Shares Outstanding (Weighted Average) history runs 13 years deep, the most recent figure standing at $148.3 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 9.11% year-over-year to $148.3 million; the TTM figure through Mar 2026 stood at $148.3 million (up 9.11% YoY), while the FY2025 annual figure was $147.4 million, up 18.77% from the prior year.
- Shares Outstanding (Weighted Average) was $148.3 million for Q1 2026 at Weed, up from $147.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $148.3 million in Q1 2026 to a low of $119.9 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $128.4 million across 5 years, with a median of $123.8 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) climbed 0.26% in 2024, then gained 18.77% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $122.1 million in 2022, then increased by 1.34% to $123.7 million in 2023, then advanced by 0.34% to $124.1 million in 2024, then climbed by 18.77% to $147.4 million in 2025, then advanced by 0.6% to $148.3 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $148.3 million (Q1 2026), $147.4 million (Q4 2025), and $135.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Weed | - | - | - | 148.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.31 Mn |
| Dec 31, 2025 | 147.43 Mn |
| Sep 30, 2025 | 135.93 Mn |
| Jun 30, 2025 | 135.93 Mn |
| Mar 31, 2025 | 135.93 Mn |
| Dec 31, 2024 | 124.13 Mn |
| Sep 30, 2024 | 125.68 Mn |
| Jun 30, 2024 | 125.18 Mn |
| Mar 31, 2024 | 123.81 Mn |
| Dec 31, 2023 | 123.71 Mn |
| Sep 30, 2023 | 123.48 Mn |
| Jun 30, 2023 | 123.48 Mn |
| Mar 31, 2023 | 123.48 Mn |
| Dec 31, 2022 | 122.08 Mn |
| Sep 30, 2022 | 122.94 Mn |
| Jun 30, 2022 | 121.91 Mn |
| Mar 31, 2022 | 119.93 Mn |
| Dec 31, 2021 | 116.73 Mn |
| Sep 30, 2021 | 117.92 Mn |
| Jun 30, 2021 | 115.15 Mn |